SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Prelude Therapeutics Incorporated backtest

10 trend-following strategies were compared on the full daily history of Prelude Therapeutics Incorporated. 10 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is Keltner 채널 돌파 (CAGR -1.1%, MDD -63.3%).

Data 2020-09-25 ~ 2026-07-31daily bars 1,468 (5.8 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -25.8%, drawdown -99.3%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 24.2%, MDD -70.1%, Sharpe 0.58, 16% exposure.

Return/drawdown alternative: Keltner 채널 돌파 — CAGR is 50.0%p higher than buy and hold, while drawdown improves by 29.2%p (CAGR -1.1%, MDD -63.3%, exposure 29%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=35, threshold=24
24.2%-70.1%0.580.353.6x816%
SMA 크로스오버
fast=51, slow=186
13.8%-73.9%0.530.192.1x532%
Supertrend
period=8, mult=2.2
10.1%-65.8%0.490.151.8x3942%
Donchian 채널 돌파
entryN=33, exitN=74
1.2%-89.9%0.460.011.1x1154%
Parabolic SAR
step=0.06, maxStep=0.12
4.6%-91.2%0.430.051.3x19143%
ROC 모멘텀
n=125, threshold=0
1.8%-80.1%0.420.021.1x3333%
EMA 크로스오버
fast=31, slow=32
-2.4%-89.6%0.39-0.030.9x2545%
Keltner 채널 돌파
emaPeriod=11, atrPeriod=18, mult=0.6
-1.1%-63.3%0.34-0.020.9x10329%
볼린저 밴드 돌파
n=57, k=3.4
-1.1%-66.2%0.26-0.020.9x68%
MACD
fast=16, slow=93, signal=34
-20.4%-89.6%0.20-0.230.3x3455%
Buy and hold-25.8%-99.3%0.30-0.260.2x1100%
0.1 1x 2021 2022 2023 2024 2025 2026 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -50% -75% -99% 2021 2022 2023 2024 2025 2026 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -70.1% (2025-11-03 → 2025-11-07), recovered after 155 days.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next